We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEVA icon
3976
Teva Pharmaceuticals
TEVA
$42.1B
$11K ﹤0.01%
889
-20,727
-96% -$234K
TX icon
3977
Ternium
TX
$10.8B
$11K ﹤0.01%
727
-2,338
-76% -$33.8K
UG icon
3978
United-Guardian
UG
$33.4M
$11K ﹤0.01%
+722
New +$10.8K
UTI icon
3979
Universal Technical Institute
UTI
$1.47B
$11K ﹤0.01%
+1,636
New +$10.7K
VEL icon
3980
Velocity Financial
VEL
$723M
$11K ﹤0.01%
+2,873
New +$10.8K
WULF icon
3981
TeraWulf
WULF
$8.08B
$11K ﹤0.01%
3,098
+2,957
+2,097% +$10.4K
AUMN
3982
DELISTED
Golden Minerals Company
AUMN
$11K ﹤0.01%
1,022
+962
+1,603% +$7.25K
NEPT
3983
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$11K ﹤0.01%
3
+1
+50% +$3.36K
AXLA
3984
DELISTED
Axcella Health Inc. Common Stock
AXLA
$11K ﹤0.01%
+82
New +$10K
ISEE
3985
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$11K ﹤0.01%
2,237
+23
+1% +$96
APEN
3986
DELISTED
Apollo Endosurgery, Inc.
APEN
$11K ﹤0.01%
7,105
+6,939
+4,180% +$13.8K
FSTX
3987
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$11K ﹤0.01%
+1,959
New +$11.3K
STON
3988
DELISTED
StoneMor Inc.
STON
$11K ﹤0.01%
+14,676
New +$10.1K
AUTO
3989
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$11K ﹤0.01%
+8,805
New +$8.62K
HSTO
3990
DELISTED
Histogen Inc. Common Stock
HSTO
$11K ﹤0.01%
+147
New +$12.3K
CNP.PRB
3991
DELISTED
CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S
CNP.PRB
$11K ﹤0.01%
300
-100
-25% -$3.34K
ALSK
3992
DELISTED
Alaska Communications Systems
ALSK
$11K ﹤0.01%
+4,126
New +$9.39K
CCXX.U
3993
DELISTED
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
$11K ﹤0.01%
+1,007
New +$10.5K
WBK
3994
DELISTED
Westpac Banking Corporation
WBK
$11K ﹤0.01%
862
-4,647
-84% -$50.9K
ALDX icon
3995
Aldeyra Therapeutics
ALDX
$91.1M
$10K ﹤0.01%
+2,434
New +$8.89K
ARL icon
3996
American Realty Investors
ARL
$243M
$10K ﹤0.01%
+1,120
New +$9.07K
ATLC icon
3997
Atlanticus Holdings
ATLC
$1.45B
$10K ﹤0.01%
1,054
+770
+271% +$10.2K
BSVN icon
3998
Bank7 Corp
BSVN
$482M
$10K ﹤0.01%
+890
New +$8.22K
SLAI
3999
DELISTED
SOLAI Ltd ADS
SLAI
$10K ﹤0.01%
37
CBUS icon
4000
Cibus
CBUS
$146M
$10K ﹤0.01%
42
+3
+8% +$672

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.